[Edaily Reporter Kwon Oh Seok ] Automotive parts specialist SJG SEJONG CO.,LTD.(033530)will cancel all 768,662 of its treasury shares. (Photo: SJG SEJONG CO.,LTD.) SJG SEJONG CO.,LTD. announced that it plans to cancel these treasury shares on the 15th. Based on the closing price of 6,000 won on June 30, this amounts to approximately 4.6 billion won. The company explained that this decision is a measure to enhance corporate value and shareholder value in line with the value-up trend in the KOSDAQ market. As a result of this cancellation, the total number of issued shares will decrease from 27,820,961 to 27,052,299. Consequently, the company expects an increase in per-share value due to the reduction in the number of shares in circulation. Since this is being carried out through the cancellation of treasury stock, there will be no change in the company’s capital. An SJG SEJONG CO.,LTD. official stated, “Business uncertainty is easing as issues related to U.S. tariffs and the war in the Middle East have stabilized somewhat,” adding, “We expect a stable sales trend to continue, driven by growing demand for hybrid vehicles.” The official continued, “In the second half of the year, we plan to communicate the company’s transformed image and value to the market through more proactive investor relations (IR) activities,” and added, “We will continue to strengthen communication with the market and pursue multifaceted strategies to enhance sustainable corporate value.”
ABLE C&C(078520)is establishing a subsidiary in the Netherlands to serve as the control tower for its European operations. Following the establishment of its UK subsidiary, the company is setting up a…
On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
As global Big Pharma companies embark on large-scale mergers and acquisitions (M&A) to overcome the patent cliff and growth limitations, there are increasing instances of Chinese biotech companies bei…